平安好医生在2024年实现了盈利,且费用控制和组织改革初见成效,但其核心业务增长动能仍显不足,营收改善幅度有限。此次管理层变动虽引入了具有财务与运营经验的臧珞琦,释放出强化治理、优化管理的信号,但总裁职位的空缺无疑为公司战略执行带来一定不确定性。近日,平安健康医疗科技有限公司(股票简称:平安好医生,股票代码:1833.HK)发布公告称,吴军因个人工作安排辞去公司执行董事及总裁职务,相关变动自即日起...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.